LGC announces new senior appointments

News (ZH) - LGC has announced three new senior appointments

Measurement for Recovery (M4R) launched to boost UK innovation

News (ZH) - M4R will run until the end of 2020 and will enable businesses to have access to the world-leading chemical and bio-measurement expertise and capabilities at the NML.

LGC and Aptahem combine on first large-scale production campaign of Apta-1

News (ZH) - First large-scale production run of Apta-1as a non-GMP material, intended for use in GLP toxicology studies

Kent consortium gets green light to develop £60million investment bid: proposal to accelerate medicines development via data and digital technology

News (ZH) - A proposal that could bring £60million investment into the life sciences sector in Kent has taken a significant stride forward by securing £50,000 to develop the bid further. The money is seedcorn funding via UK Research and Innovation’s flagship £236m Strength in Places Fund.

LGC SeraCare SARS-CoV-2 Molecular Controls Kit now CE-Marked

News (ZH) - Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements

Proficiency Testing in the COVID-19 pandemic

博客 - Proficiency testing (PT), often known as External Quality Assessment (EQA) in the clinical sector, allows laboratories to assess their measurement processes with test materials that we send them

LGC expands SARS-CoV-2 molecular solutions to full genome coverage

News (ZH) - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News (ZH) - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

NML response to the Research and Development Roadmap

News (ZH) - The National Measurement Laboratory (NML), hosted at LGC, welcomes the publication of the UK government’s Research and Development (R&D) Roadmap with its ongoing commitment to increased investment in R&D to cement the UK’s world-leading position within science and research and support the individuals behind it

The importance of standardisation of diagnostic measurements in the COVID-19 pandemic

博客 - Dr Jim Huggett, Principal Scientist at the NML at LGC, recently answered some of our questions around why standardised measurement is so important to medicine.